Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Woude, C.J. van der"'
Autor:
Arkenbosch, J.H.C., Beelen, E.M.J., Dijkstra, G., Romberg-Camps, M., Duijvestein, M., Hoentjen, F., Marel, S. van der, Maljaars, P.W.J., Jansen, S., Boer, N.K.H. de, West, R.L., Horjus, C.S., Stassen, L.P.S., Schaik, F.D.M. van, Ruler, O. van, Jharap, B.J.H., Visschedijk, M., Janssen, A., Erler, N.S., Doukas, M., Ooms, A.H.A.G., Kats-Ugurlu, G., Woude, C.J. van der, Vries, A.C. de, Dutch Initiative Crohns Colitis IC
Publikováno v:
Arkenbosch, J H C, Beelen, E M J, Dijkstra, G, Romberg-Camps, M, Duijvestein, M, Hoentjen, F, van der Marel, S, Maljaars, P W J, Jansen, S, de Boer, N K H, West, R L, Horjus, C S, Stassen, L P S, van Schaik, F D M, van Ruler, O, Jharap, B J H, Visschedijk, M, Janssen, A, Erler, N S, Doukas, M, Ooms, A H A G, Kats-Ugurlu, G, van der Woude, C J & de Vries, A C 2023, ' Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease : a Prospective Study Based on Clinical Risk Stratification ', Journal of Crohn's & colitis, vol. 17, no. 2, pp. 221-230 . https://doi.org/10.1093/ecco-jcc/jjac128
Journal of Crohn's & Colitis, 17(2), 221-230. Oxford University Press
Journal of Crohn's & colitis, 17(2), 221-230. Oxford University Press
Journal of Crohn's and Colitis, 17, 2, pp. 221-230
Journal of Crohn's & colitis, 17(2), 221-230. Elsevier
Journal of Crohn's and Colitis, 17, 221-230
Journal of Crohn's and Colitis. OXFORD UNIV PRESS
Journal of Crohn's and Colitis
Journal of Crohn's & Colitis, 17(2), 221-230. Oxford University Press
Journal of Crohn's & colitis, 17(2), 221-230. Oxford University Press
Journal of Crohn's and Colitis, 17, 2, pp. 221-230
Journal of Crohn's & colitis, 17(2), 221-230. Elsevier
Journal of Crohn's and Colitis, 17, 221-230
Journal of Crohn's and Colitis. OXFORD UNIV PRESS
Journal of Crohn's and Colitis
Background To prevent recurrence after ileocolonic resection [ICR] in Crohn’s disease [CD], postoperative prophylaxis based on risk stratification is recommended in international guidelines. This study aimed to evaluate postoperative CD recurrence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21490f0274ff709879e0be36bf707cdd
https://research.vumc.nl/en/publications/946c5e9e-f9e6-4d0d-abe8-c9dbc2b2cbeb
https://research.vumc.nl/en/publications/946c5e9e-f9e6-4d0d-abe8-c9dbc2b2cbeb
Autor:
Huinink, S.T., Beelen, E.M.J., Huinink, T.T., Hoentjen, F., Bodelier, A.G.L., Dijkstra, G., Romberg-Camps, M., Boer, N.K. de, Stassen, L.P.S., Meulen, A.E. van der, West, R., Ruler, O. van, Woude, C.J. van der, Vries, A.C. de, Dutch ICC
Publikováno v:
European Journal of Gastroenterology & Hepatology, 35(1), 45-51. LIPPINCOTT WILLIAMS & WILKINS
Background: A considerable proportion of Crohn's disease patients that undergo ileocecal resection (ICR) have failed anti-tumor necrosis factor (TNF) therapy preoperatively. This study aimed to assess the effectiveness of retreatment of anti-TNF ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::96f66393cacedbc0d702d57b1adb943f
https://hdl.handle.net/1887/3593860
https://hdl.handle.net/1887/3593860
Autor:
Huinink, S.T., Jong, D.C. de, Nieboer, D., Thomassen, D., Steyerberg, E.W., Dijkgraaf, M.G.W., Bodelier, A.G.L., West, R.L., Romkens, T.E.H., Hoentjen, F., Mallant, R.C., Tuyl, B.A.C. van, Mares, W.G.N., Wolfhagen, F.H.J., Dijkstra, G., Reijnders, J.G.P., Boer, N.K. de, Tan, A.C.I.T.L., Boeckel, P.G.A. van, Tack, G.J., Asseldonk, D.P. van, D'Haens, G.R.A.M., Woude, C.J. van der, Duijvestein, M., Vries, A.C. de
Publikováno v:
European journal of gastroenterology & hepatology, 34(10), 983-992. Lippincott Williams and Wilkins
European Journal of Gastroenterology & Hepatology, 34, 983-992
European journal of gastroenterology & hepatology, 34(10), 983-992. Lippincott Williams & Wilkins
European Journal of Gastroenterology & Hepatology, 34, 10, pp. 983-992
European Journal of Gastroenterology & Hepatology, 34(10), 983-992. LIPPINCOTT WILLIAMS & WILKINS
ten Bokkel Huinink, S, de Jong, D C, Nieboer, D, Thomassen, D, Steyerberg, E W, Dijkgraaf, M G W, Bodelier, A G L, West, R L, Römkens, T E H, Hoentjen, F, Mallant, R C, van Tuyl, B A C, Mares, W G N, Wolfhagen, F H J, Dijkstra, G, Reijnders, J G P, de Boer, N K, Tan, A C I T L, van Boeckel, P G A, Tack, G J, van Asseldonk, D P, D'Haens, G R A M, van der Woude, C J, Duijvestein, M & de Vries, A C 2022, ' Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn's disease ', European journal of gastroenterology & hepatology, vol. 34, no. 10, pp. 983-992 . https://doi.org/10.1097/MEG.0000000000002403
European Journal of Gastroenterology & Hepatology, 34, 983-992
European journal of gastroenterology & hepatology, 34(10), 983-992. Lippincott Williams & Wilkins
European Journal of Gastroenterology & Hepatology, 34, 10, pp. 983-992
European Journal of Gastroenterology & Hepatology, 34(10), 983-992. LIPPINCOTT WILLIAMS & WILKINS
ten Bokkel Huinink, S, de Jong, D C, Nieboer, D, Thomassen, D, Steyerberg, E W, Dijkgraaf, M G W, Bodelier, A G L, West, R L, Römkens, T E H, Hoentjen, F, Mallant, R C, van Tuyl, B A C, Mares, W G N, Wolfhagen, F H J, Dijkstra, G, Reijnders, J G P, de Boer, N K, Tan, A C I T L, van Boeckel, P G A, Tack, G J, van Asseldonk, D P, D'Haens, G R A M, van der Woude, C J, Duijvestein, M & de Vries, A C 2022, ' Validation and update of a prediction model for risk of relapse after cessation of anti-TNF treatment in Crohn's disease ', European journal of gastroenterology & hepatology, vol. 34, no. 10, pp. 983-992 . https://doi.org/10.1097/MEG.0000000000002403
BACKGROUND: Anti-tumor necrosis factor (TNF) therapy is effective for the treatment of Crohn's disease. Cessation may be considered in patients with a low risk of relapse. We aimed to externally validate and update our previously developed prediction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48a17de86d4eacf6d66f3e5e97f5bb99
https://hdl.handle.net/1887/3564559
https://hdl.handle.net/1887/3564559
Autor:
Voskuil, M.D., Spekhorst, L.M., Sloot, K.W.J. van der, Jansen, B.H., Dijkstra, G., Woude, C.J. van der, Hoentjen, F., Pierik, M.J., Meulen, A.E. van der, Boer, N.K.H. de, Lowenberg, M., Oldenburg, B., Festen, E.A.M., Weersma, R.K., Parelsnoer Inst, Dutch Initiative Crohn Colitis
Publikováno v:
Journal of Crohn's and Colitis, 15(6), 930-937. Oxford University Press
Journal of Crohn's and Colitis, 15(6), 930-937. Elsevier
Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis 2021, ' Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes ', Journal of Crohn's and Colitis, vol. 15, no. 6, pp. 930-937 . https://doi.org/10.1093/ecco-jcc/jjaa223
Journal of Crohn's and Colitis, 15, 930-937
Journal of Crohn's and Colitis, 15, 6, pp. 930-937
Journal of Crohn's & Colitis, 15(6), 930-937. Oxford University Press
Journal of Crohn's and Colitis, 15(6), 930-937. OXFORD UNIV PRESS
Journal of Crohn's and Colitis, 15(6), 930-937. Elsevier
Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis 2021, ' Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes ', Journal of Crohn's and Colitis, vol. 15, no. 6, pp. 930-937 . https://doi.org/10.1093/ecco-jcc/jjaa223
Journal of Crohn's and Colitis, 15, 930-937
Journal of Crohn's and Colitis, 15, 6, pp. 930-937
Journal of Crohn's & Colitis, 15(6), 930-937. Oxford University Press
Journal of Crohn's and Colitis, 15(6), 930-937. OXFORD UNIV PRESS
Background and Aims Inflammatory bowel disease [IBD] phenotypes are very heterogeneous between patients, and current clinical and molecular classifications do not accurately predict the course that IBD will take over time. Genetic determinants of dis
Autor:
Kanis, S.L., Modderman, S., Escher, J.C., Erler, N., Beukers, R., Boer, N. de, Bodelier, A., Depla, A.C.T.M., Dijkstra, G., Dijk, A.B.R.M. van, Gilissen, L., Hoentjen, F., Jansen, J.M., Kuyvenhoven, J., Mahmmod, N., Mallant-Hent, R.C., Meulen-de Jong, A.E. van der, Noruzi, A., Oldenburg, B., Oostenbrug, L.E., Borg, P.C.J. ter, Pierik, M., Romberg-Camps, M., Thijs, W., West, R., Lima, A. de, Woude, C.J. van der, Initiative Crohns Colitis ICC
Publikováno v:
Gut, 70, 7, pp. 1266-1274
Gut
Gut, 70, 1266-1274
Gut, 70(7). BMJ PUBLISHING GROUP
Kanis, S L, Modderman, S, Escher, J C, Erler, N, Beukers, R, De Boer, N, Bodelier, A, Depla, A C T M, Dijkstra, G, Van Dijk, A B R M, Gilissen, L, Hoentjen, F, Jansen, J M, Kuyvenhoven, J, Mahmmod, N, Mallant-Hent, R C, Van Der Meulen-De Jong, A E, Noruzi, A, Oldenburg, B, Oostenbrug, L E, Ter Borg, P C J, Pierik, M, Romberg-Camps, M, Thijs, W, West, R, De Lima, A & Van Der Woude, C J 2021, ' Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life ', Gut, vol. 70, no. 7, pp. 1266-1274 . https://doi.org/10.1136/gutjnl-2019-319129
Gut, 70(7), 1266-1274. BMJ PUBLISHING GROUP
Gut, 70(7), 1266-1274. BMJ Publishing Group
Gut
Gut, 70, 1266-1274
Gut, 70(7). BMJ PUBLISHING GROUP
Kanis, S L, Modderman, S, Escher, J C, Erler, N, Beukers, R, De Boer, N, Bodelier, A, Depla, A C T M, Dijkstra, G, Van Dijk, A B R M, Gilissen, L, Hoentjen, F, Jansen, J M, Kuyvenhoven, J, Mahmmod, N, Mallant-Hent, R C, Van Der Meulen-De Jong, A E, Noruzi, A, Oldenburg, B, Oostenbrug, L E, Ter Borg, P C J, Pierik, M, Romberg-Camps, M, Thijs, W, West, R, De Lima, A & Van Der Woude, C J 2021, ' Health outcomes of 1000 children born to mothers with inflammatory bowel disease in their first 5 years of life ', Gut, vol. 70, no. 7, pp. 1266-1274 . https://doi.org/10.1136/gutjnl-2019-319129
Gut, 70(7), 1266-1274. BMJ PUBLISHING GROUP
Gut, 70(7), 1266-1274. BMJ Publishing Group
ObjectiveThe aim of this study was to describe the long-term health outcomes of children born to mothers with inflammatory bowel disease (IBD) and to assess the impact of maternal IBD medication use on these outcomes.DesignWe performed a multicentre
Autor:
Rouvroye, M.D., Tack, G.J., Mom, C.H., Lissenberg-Witte, B.I., Pierik, M.J., Neefjes-Borst, E.A., Boer, N.K.H. de, Lowenberg, M., Bodelier, A., Verbeek, W.H., Schoon, E., Witteman, E.M., Herwaarden, M.A., Woude, C.J. van der, Lutgens, M., Kouw, E., Veek, P.J. van der, Hulst, R.W. van der, Sipkema, H., Nissen, L.H.C., Bus, P.J., Meulen, A.E. van der, Bruijne, F.H. de, Waaij, L.A. van der, Noomen, C.G., Jharap, B., Schmittgens, S., Jansen, J.M., Hoentjen, F., Lammertink, M.H.A., Houben, G.M.P., Minderhoud, I.M., Dijkstra, G., Oldenburg, B., Sikkens, M.S.G., Tuyl, S.A. van, Bodegraven, A.A. van, Dutch Workgrp IBD Vulvovaginal Neo
Publikováno v:
Digestive and Liver Disease, 52, 2, pp. 149-155
Digestive and liver disease, 52(2). Elsevier
Digestive and Liver Disease, 52(2), 149-155. Elsevier Science
Digestive and Liver Disease, 52, 149-155
Dutch Workgroup on IBD and Vulvovaginal neoplasia 2020, ' Vulvar and vaginal neoplasia in women with inflammatory bowel disease ', Digestive and Liver Disease, vol. 52, no. 2, pp. 149-155 . https://doi.org/10.1016/j.dld.2019.10.002
Digestive and Liver Disease, 52(2), 149-155. Elsevier
Digestive and Liver Disease, 52(2), 149-155. ELSEVIER SCIENCE INC
Digestive and liver disease, 52(2), 149. Elsevier
Digestive and liver disease, 52(2). Elsevier
Digestive and Liver Disease, 52(2), 149-155. Elsevier Science
Digestive and Liver Disease, 52, 149-155
Dutch Workgroup on IBD and Vulvovaginal neoplasia 2020, ' Vulvar and vaginal neoplasia in women with inflammatory bowel disease ', Digestive and Liver Disease, vol. 52, no. 2, pp. 149-155 . https://doi.org/10.1016/j.dld.2019.10.002
Digestive and Liver Disease, 52(2), 149-155. Elsevier
Digestive and Liver Disease, 52(2), 149-155. ELSEVIER SCIENCE INC
Digestive and liver disease, 52(2), 149. Elsevier
Immunosuppressive drugs are the cornerstone in the treatment of inflammatory bowel disease (IBD), however they are associated with an increased risk of extra-intestinal cancer. Whether the risk for female genital tract malignancies, including vulvar
Autor:
Goetgebuer, R.L., Kreijne, J.E., Aitken, C.A., Dijkstra, G., Hoentjen, F., Boer, N.K. de, Oldenburg, B., Meulen, A.E. van der, Ponsioen, C.I.J., Pierik, M.J., Kemenade, F.J. van, Kok, I.M.C.M. de, Siebers, A.G., Mannien, J., Woude, C.J. van der, Vries, A.C. de, Dutch Initiative Crohn Colitis ICC
Publikováno v:
Goetgebuer, R L, Kreijne, J E, Aitken, C A, Dijkstra, G, Hoentjen, F, de Boer, N K, Oldenburg, B, van der Meulen, A E, Ponsioen, C I J, Pierik, M J, van Kemenade, F J, de Kok, I M C M, Siebers, A G, Manniën, J, van der Woude, C J & de Vries, A C 2021, ' Increased Risk of High-grade Cervical Neoplasia in Women with Inflammatory Bowel Disease : A Case-controlled Cohort Study ', Journal of Crohn's & colitis, vol. 15, no. 9, pp. 1464-1473 . https://doi.org/10.1093/ecco-jcc/jjab036
Journal of Crohn's & colitis, 15(9), 1464-1473. Elsevier
Journal of Crohn's and Colitis, 15, 9, pp. 1464-1473
Journal of Crohn's and Colitis, 15(9), 1464-1473. Oxford University Press
Journal of Crohn's & Colitis, 15(9), 1464-1473. Oxford University Press
Journal of Crohn's and Colitis, 15(9), 1464-1473. OXFORD UNIV PRESS
Journal of Crohn's & colitis, 15(9), 1464-1473. Oxford University Press
Journal of Crohn's and Colitis, 15, 1464-1473
Journal of Crohn's & Colitis
Journal of Crohn's & colitis, 15(9), 1464-1473. Elsevier
Journal of Crohn's and Colitis, 15, 9, pp. 1464-1473
Journal of Crohn's and Colitis, 15(9), 1464-1473. Oxford University Press
Journal of Crohn's & Colitis, 15(9), 1464-1473. Oxford University Press
Journal of Crohn's and Colitis, 15(9), 1464-1473. OXFORD UNIV PRESS
Journal of Crohn's & colitis, 15(9), 1464-1473. Oxford University Press
Journal of Crohn's and Colitis, 15, 1464-1473
Journal of Crohn's & Colitis
Background and Aims Women with inflammatory bowel disease [IBD] may be at higher risk for cervical intraepithelial neoplasia [CIN]. However, data are conflicting. The aim of this study was to assess the risk of high-grade dysplasia and cancer [CIN2+]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44cf3a9541183ab1723fd7e15c80fc8
https://research.vumc.nl/en/publications/a99c78be-24d6-4748-92a7-ce01dbaa59d7
https://research.vumc.nl/en/publications/a99c78be-24d6-4748-92a7-ce01dbaa59d7
Autor:
Beelen, E.M.J., Woude, C.J. van der, Pierik, M.J., Hoentjen, F., Boer, N.K. de, Oldenburg, B., Meulen, A.E. van der, Ponsioen, C.I.J., Dijkstra, G., Bruggink, A.H., Erler, N.S., Schouten, W.R., Vries, A.C. de, Dutch Initiative Crohn's Colitis
Publikováno v:
Annals of Surgery, 273, 3, pp. 557-563
Annals of Surgery, 273, 557-563
Annals of Surgery, 273(3), 557-563. LIPPINCOTT WILLIAMS & WILKINS
Annals of Surgery, 273(3), 557-563. Lippincott Williams and Wilkins
Beelen, E M J, van der Woude, C J, Pierik, M J, Hoentjen, F, de Boer, N K, Oldenburg, B, van der Meulen, A E, Ponsioen, C I J, Dijkstra, G, Bruggink, A H, Erler, N S, Schouten, W R, de Vries, A C & Dutch Initiative on Crohnʼs and Colitis (ICC) 2021, ' Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease : A Nationwide Cohort Study ', Annals of Surgery, vol. 273, no. 3, pp. 557-563 . https://doi.org/10.1097/SLA.0000000000003395
Annals of Surgery, 273(3), 557-563. Lippincott Williams & Wilkins
Annals of Surgery, 273, 557-563
Annals of Surgery, 273(3), 557-563. LIPPINCOTT WILLIAMS & WILKINS
Annals of Surgery, 273(3), 557-563. Lippincott Williams and Wilkins
Beelen, E M J, van der Woude, C J, Pierik, M J, Hoentjen, F, de Boer, N K, Oldenburg, B, van der Meulen, A E, Ponsioen, C I J, Dijkstra, G, Bruggink, A H, Erler, N S, Schouten, W R, de Vries, A C & Dutch Initiative on Crohnʼs and Colitis (ICC) 2021, ' Decreasing Trends in Intestinal Resection and Re-Resection in Crohn's Disease : A Nationwide Cohort Study ', Annals of Surgery, vol. 273, no. 3, pp. 557-563 . https://doi.org/10.1097/SLA.0000000000003395
Annals of Surgery, 273(3), 557-563. Lippincott Williams & Wilkins
OBJECTIVE: To assess time trends in intestinal resection and re-resection in Crohn's disease (CD) patients. SUMMARY OF BACKGROUND DATA: CD treatment has changed considerably over the past decades. The effect of these advances on the necessity of inte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a091ec60e0e6a82a42566b1e358c771
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/231079
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/231079
Autor:
Biemans, V.B.C., Woude, C.J. van der, Dijkstra, G., Meulen-de Jong, A.E. van der, Lowenberg, M., Boer, N.K. de, Oldenburg, B., Srivastava, N., Jansen, J.M., Bodelier, A.G.L., West, R.L., Vries, A.C. de, Haans, J.J.L., Jong, D. de, Hoentjen, F., Pierik, M.J., Dutch Initiative Crohn Colitis ICC
Publikováno v:
Alimentary Pharmacology & Therapeutics, 52(1), 123-134. Wiley
Biemans, V B C, van der Woude, C J, Dijkstra, G, van der Meulen-de Jong, A E, Löwenberg, M, de Boer, N K, Oldenburg, B, Srivastava, N, Jansen, J M, Bodelier, A G L, West, R L, de Vries, A C, Haans, J J L, de Jong, D, Hoentjen, F & Pierik, M J 2020, ' Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti-TNF treatment ', Alimentary Pharmacology and Therapeutics, vol. 52, no. 1, pp. 123-134 . https://doi.org/10.1111/apt.15745
Alimentary Pharmacology & Therapeutics, 52, 1, pp. 123-134
Alimentary pharmacology & therapeutics, 52(1), 123-134. Wiley-Blackwell
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology & Therapeutics, 52(1), 123-134. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics, 52, 123-134
Alimentary Pharmacology and Therapeutics, 52(1), 123-134. WILEY
Alimentary Pharmacology and Therapeutics, 52(1), 123-134
Biemans, V B C, van der Woude, C J, Dijkstra, G, van der Meulen-de Jong, A E, Löwenberg, M, de Boer, N K, Oldenburg, B, Srivastava, N, Jansen, J M, Bodelier, A G L, West, R L, de Vries, A C, Haans, J J L, de Jong, D, Hoentjen, F & Pierik, M J 2020, ' Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti-TNF treatment ', Alimentary Pharmacology and Therapeutics, vol. 52, no. 1, pp. 123-134 . https://doi.org/10.1111/apt.15745
Alimentary Pharmacology & Therapeutics, 52, 1, pp. 123-134
Alimentary pharmacology & therapeutics, 52(1), 123-134. Wiley-Blackwell
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology & Therapeutics, 52(1), 123-134. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology & Therapeutics, 52, 123-134
Alimentary Pharmacology and Therapeutics, 52(1), 123-134. WILEY
Alimentary Pharmacology and Therapeutics, 52(1), 123-134
Contains fulltext : 220027.pdf (Publisher’s version ) (Open Access) BACKGROUND: Both vedolizumab and ustekinumab can be considered for the treatment of Crohn's disease (CD) when anti-TNF treatment fails. However, head-to-head trials are currently n
Autor:
Meijer, B., Mulder, C.J.J., Bouma, G., Ponsioen, C.Y., Woude, C.J. van der, Meulen, A.E. van der, Wintjens, D.S.J., Dijkstra, G., Hoentjen, F., Oldenburg, B., Bodegraven, A.A. van, Boer, N.K.H. de, Dutch Initiative Crohn Colitis ICC
Publikováno v:
Meijer, B, Mulder, C J J, Bouma, G, Ponsioen, C Y, van der Woude, C J, van der Meulen, A E, Wintjens, D S J, Dijkstra, G, Hoentjen, F, Oldenburg, B, van Bodegraven, A A & de Boer, N K H 2018, ' Methotrexate and thioguanine rescue therapy for conventional thiopurine failing ulcerative colitis patients: A multi-center database study on tolerability and effectiveness ', Inflammatory Bowel Diseases, vol. 24, no. 7, pp. 1558-1565 . https://doi.org/10.1093/ibd/izy047
Inflammatory Bowel Diseases, 24, 1558-1565
Inflammatory Bowel Diseases, 24(7), 1558-1565. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 24(7), 1558-1565. Oxford University Press
Inflammatory Bowel Diseases, 24, 7, pp. 1558-1565
Inflammatory Bowel Diseases, 24(7), 1558-1565
Inflammatory Bowel Diseases, 24(7), 1558-1565. John Wiley and Sons Inc.
Inflammatory bowel diseases, 24(7), 1558-1565. John Wiley and Sons Inc.
Inflammatory Bowel Diseases, 24, 1558-1565
Inflammatory Bowel Diseases, 24(7), 1558-1565. LIPPINCOTT WILLIAMS & WILKINS
Inflammatory Bowel Diseases, 24(7), 1558-1565. Oxford University Press
Inflammatory Bowel Diseases, 24, 7, pp. 1558-1565
Inflammatory Bowel Diseases, 24(7), 1558-1565
Inflammatory Bowel Diseases, 24(7), 1558-1565. John Wiley and Sons Inc.
Inflammatory bowel diseases, 24(7), 1558-1565. John Wiley and Sons Inc.
Item does not contain fulltext Background: Patients with active ulcerative colitis (UC) failing conventional therapies are in need of rescue strategies. Due to the fact that accepted step-up therapy with biologicals is expensive and sometimes unavail